USE OF ONCOLYTIC HERPES SIMPLEX VIRUS, ALONE OR IN COMBINATION WITH IMMUNE CHECK-POINT INHIBITOR, IN THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

VIRTTU BIOLOGICS LIMITED

发明人:

Joe Conner

申请号：

US15875757

公开号：

US20180207212A1

申请日:

2018.01.19

申请国别(地区):

US

年份:

2018

代理人:

摘要：

An oncolytic herpes simplex virus is disclosed for use in a method of treating cancer, the method comprising administering one or more doses of an oncolytic herpes simplex virus effective to induce a Th1 immune response in the subject, and optionally administering a therapeutically effective amount of an immune checkpoint inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/